Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 3, 2006, Pages 261-270

  Pires, Viviane Silva ^a   Gaboriau, François ^b   Guillon, Jean ^c   da Nascimento, Sophie ^a   Dassonville, Alexandra ^a   Lescoat, Gerard ^b   Desplat, Vanessa ^d   Rochette, Jacques ^a   Jarry, Christian ^c   Sonnet, Pascal ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c Laboratoire de Pharmacochimie   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Antiproliferative effect; Calix 4 arene; Conformation; Hepatocyte; Iron chelator

Indexed keywords

25,26,27 TRIHYDROXY 28 (HYDRAZINOCARBONYLMETHOXY)CALIX[4]ARENE; 25,27 DIHYDROXY 26,28 BIS(ASPARTYLCARBONYLMETHOXY)CALIX[4]ARENE DERIVATIVE; 25,27 DIHYDROXY 26,28 BIS(DIMETHYLGLUTAMYLCARBONYLMETHOXY)CALIX[4]ARENE DERIVATIVE; 25,27 DIHYDROXY 26,28 BIS(GLUTAMYLCARBONYLMETHOXY)CALIX[4]ARENE DERIVATIVE; 25,27 DIHYDROXY 26,28 BIS(O,O' DIMETHYLASPARTYL)CALIX[4]ARENE DERIVATIVE; 25,27 DIHYDROXY 26,28 BIS(O,O' DIMETHYLASPARTYLCARBONYLMETHOXY)CALIX[4]ARENE; 25,27 DIHYDROXY 26,28 BIS(O,O' DIMETHYLGLUTAMYLCARBONYLMETHOXY)CALIX[4]ARENE DERIVATIVE; 25,27 DIHYDROXY 26,28 BIS[(N' BENZYLOXYCARBONYLORNITHYL)CARBONYLMETHOXY]CALIX[4]ARENE; 25,27 DIHYDROXY 26,28 BIS[(O DIMETHYL N' BENZYLOXYCARBONYLORNITHYL)CARBONYLMETHOXY]CALIX[4]ARENE; 25,27 DIHYDROXY 26,28 BIS[(ORNITHYL)CARBONYLMETHOXY]CALIX[4]ARENE; ANTINEOPLASTIC AGENT; CALIX[4]ARENE DERIVATIVE; COPPER SULFATE; DEFERASIROX; FERROUS SULFATE; IRON CHELATING AGENT; LACTATE DEHYDROGENASE; MITOCHONDRIAL ENZYME; MONOHYDRAZIDOCALIX[4]ARENE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; ZINC SULFATE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HEPATOMA CELL; IRON CHELATION; IRON DEPLETION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOIC ACIDS; CALIXARENES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HYDROXYL RADICAL; IRON CHELATING AGENTS; MOLECULAR STRUCTURE; PHENOLS; RATS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 33746179159     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600700384     Document Type: Article

References (41)

1. McCance, RA and Widdowson, EM. (1937) Absorption and excretion of iron Lancet, ii, pp. 680-684.
2. Deugnier, Y and Charalambous, P and Le Quilleuc, D and Turlin, B and Searle, J and Brissot, P and Powell, LW and Halliday, JW. (1993) Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients Hepatology, 18, pp. 1363-1369.
3. Hsing, AW and McLaughlin, JK and Olsen, JH and Mellemkjar, L and Wacholder, S and Fraumeni, JF. (1995) Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark Int J Cancer, 60, pp. 160-162.
4. Chenoufi, N and Loréal, O and Drénou, B and Cariou, S and Hubert, N and Leroyer, P and Brissot, P and Lescoat, G. (1995) Iron may induce DNA synthesis and repair in rat hepatocytes stimulated by EGF/ pyruvate J Hepatol, 26, pp. 650-658.
5. Hann, HWL and Stahlhut, MW and Blumberg, BS. (1988) Iron nutrition and tumor growth: Decreased tumor growth in iron deficient mice Cancer Res, 48, pp. 4168-4170.
6. Thompson, HJ and Kennedy, K and Witt, M and Juzefyk, J. (1991) Effect of dietary iron deficiency or excess on the induction of mammary carcinogenenis by 1-methyl-1-nitrosourea Carcinogenesis, 12, pp. 111-114.
7. Tarao, K and Shimizu, A and Ohkawa, S and Harada, M and Ito, Y and Tamai, S and Kuni, Y and Okamoto, N and Inoue, T and Kanisawa, M. (1992) Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis Gastroenterol, 103, pp. 595-600.
8. Ballardini, G and Groff, P and Zoli, M and Bianchi, G and Giostra, F and Francesconi, R and Lenzi, M and Zauli, D and Cassani, F and Bianchi, F. (1994) Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation J Hepatol, 20, pp. 218-222.
9. Soyano, A and Chinea, M and Romano, EL. (1984) The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro Immunopharmacol, 8, pp. 163-169.
10. Polson, RJ and Jenkins, R and Lombard, M and Williams, AC and Roberts, S and Nouri-Aria, K and Williams, R and Bomford, A. (1990) Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine Immunology, 71, pp. 176-181.
11. Richardson, DR and Milnes, K. (1997) The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone Blood, 89, pp. 3025-3038.
12. Chenoufi, N and Baffet, G and Drénou, B and Cariou, S and Desille, M and Clément, B and Brissot, P and Lescoat, G and Loréal, O. (1997) Deferoxamine arrests in vitro the proliferation of porcine hepatocyte in G1 phase of the cell cycle Liver, 18, pp. 60-67.
13. Chenoufi, N and Drénou, B and Loréal, O and Pigeon, C and Brissot, P and Lescoat, G. (1998) Antiproliferative effect of deferiprone on the HepG2 cell line Biochem Pharmacol, 56, pp. 431-437.
14. Rakba, N and Loyer, P and Gilot, D and Delcros, JG and Glaise, D and Baret, P and Pierre, JL and Brissot, P and Lescoat, G. (2000) Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines Carcinogenesis, 21, pp. 943-951.
15. Brodie, C and Siriwardana, G and Lucas, J and Schleicher, R and Terada, N and Szepesi, A and Gelfand, E and Seligman, P. (1993) Neuroblastoma sensitivity to growth inhibition by desferrioxamine: Evidence for a block in G1 phase of the cell cycle Cancer Res, 53, pp. 3968-3975.
16. Glickstein, H and Breuer, W and Loyevsky, M and Konijn, AM and Shanzer, A and Cabantchik, ZI. (1996) Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells Blood, 87, pp. 4871-4878.
17. Valle, P and Timeus, F and Piglione, M and Rosso, P and di Montezemolo, LC and Crescenzio, N and Marranca, D and Ramenghi, U. (1995) Effect of different exposures to desferrioxamine on neuroblastoma cell lines Pediatr Hematol Oncol, 12, pp. 439-446.
18. Olivieri, NF and Koren, G and Matsui, D and Liu, PP and Blendis, L and Cameron, R and McClelland, RA and Templeton, DM. (1992) Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia Blood, 79, pp. 2741-2748.
19. Al-Refaie, FN and Wonke, B and Hoffbrand, AV and Wickens, DG and Nortey, P and Kontoghiorges, GJ. (1992) Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major Blood, 80, pp. 593-599.
20. Collins, AF and Fassos, FF and Stobie, S and Lewis, N and Shaw, D and Fry, M and Templeton, DM and McClelland, RA and Koren, G and Olivieri, NF. (1994) Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease Blood, 83, pp. 2329-2333.
21. Porter, JB and Davis, BA. (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia Best Pract Res Clin Haematol, 15, pp. 329-368.
22. Caris, C and Baret, P and Beguin, C and Serratrice, G and Pierre, JL and Laulhere, JP. (1995) Metabolization of iron by plant cells using O-Trensox, a high-affinity abiotic iron-chelating agent Biochem J, 312, pp. 879-885.
23. Unpublished results.
24. Gutsche, CD. (1998) Calixarenes revisited, Monographs in Supramolecular Chemistry. In. London, UK: The Royal Society of Chemistry.
25. Vicens, J and Böhmer, V. (1991) Calixarenes, A Versatile Class of Macrocyclic Compounds; Topics in Inclusion Science. In. Dordrecht, The Netherlands: Kluwer Academic Press.
26. Böhmer, V. (1995) Calixarenes, macrocycles with (almost) unlimited possibilities Angew Chem Int Ed Engl, 34, pp. 713-745.
27. Sansone, F and Segura, M and Ungaro, R. (2001) Calixarenes in Bioorganic and Biomimetic Chemistry. In Calixarenes 2001. (pp. 496-512). Dordrecht, The Netherlands: Kluwer Academic Publishers.
28. Lamartine, R and Tsukada, M and Shirata, A. (2002) Antimicrobial activity of calixarenes C R Chimie, 5, pp. 1-7.
29. Da Silva, E and Ficheux, D and Coleman, AW. (2005) Anti-thrombotic activity of water-soluble calix[n]arenes J Inclusion Phenom Macrocyclic Chem, 52, pp. 201-206.
30. Guillon, J and Léger, JM and Sonnet, P and Jarry, C and Robba, M. (2000) Synthesis of cone, partial-cone and 1,3-alternate 25,27-bis[1-(2-ethyl)hexyl]- and 25,27-bis[1-(2-tert-butoxy)ethyl]calix[4]arene-crown-6 conformers as potential selective cesium extractants J Org Chem, 65, pp. 8283-8289.
31. Guillon, J and Sonnet, P and Malval, JP and Massip, S and Gosse, I and Léger, JM and Lapouyade, R and Rochette, J and Monti, JP and Jarry, C. (2002) Synthesis and cesium binding affinity of new 25,27-bis(alkyloxy)calix[4]arene-crown-6 conformers in relation to the alkyl pendent moiety Supramol Chem, 14, pp. 437-450.
32. Guillon, J and Léger, JM and Dapremont, C and Denis, LA and Sonnet, P and Massip, S and Jarry, C. (2004) First synthesis of 1,3-alternate 25,27-dialkyloxy-5,17-diarylcalix[4]arenes-crown-6 as new cesium selective extracants by Suzuki cross-coupling reaction Supramol Chem, 16, pp. 319-329.
33. Deschatrette, J and Weiss, MC. (1974) Characterization of differentiated clones from a rat hepatoma Biochimie, 56, pp. 1603-1611.
34. Gaboriau, F and Delcros, JG and Moulinoux, JP. (2002) A simple assay for the measurement of plasma antioxidant status using spontaneous autoxidation of homovanillic acid J Pharmacol Toxicol Methods, 47, pp. 33-43.
35. Aoki, I and Sakaki, T and Shinkai, S. (1992) A new metal sensory system based on intramolecular fluorescence quenching on the ionophoric calix[4]arene ring J Chem Soc, Chem Commun, pp. 730-732.
36. 4 J Org Chem, 59, pp. 3683-3686.
37. Kubo, Y and Tokit, S and Kojima, Y and Osano, YT and Matsuzaki, T. (1996) A new family of indoaniline-derived calix[4]arenes: Synthesis and optical recognition properties as a chromogenic receptor J Org Chem, 61, pp. 3758-3765.
38. Arena, G and Casnati, A and Mirone, L and Sciotto, D and Ungaro, R. (1997) A new water-soluble calix[4]arene ditopic receptor rigidified by microsolvation: Acid-base and inclusion properties Tetrahedron Lett, 38, pp. 1999-2002.
39. Collins, EM and McKervey, A and Harris, SJ. (1989) Molecular receptors with calix[4]arene substructure. Synthesis of derivatives with mixed ligating functional groups J Chem Soc, Perkin Trans 1, pp. 372-374.
40. Collins, EM and McKervey, A and Madigan, E and Moran, MB and Owens, M and Ferguson, G and Harris, SJ. (1991) Chemically modified calix[4]arenes. Regioselective synthesis of 1,3-(distal) derivatives and related compounds. X-ray crystal structure of a diphenol-dinitrile J Chem Soc, Perkin Trans 1, pp. 3137-3142.
41. Franceschini, N and Da Nascimento, S and Sonnet, P and Guillaume, D. (2003) Efficient enantioselective synthesis of 2-substituted thiomorpholin-3-ones Tetrahedron: Asymmetry, 14, pp. 3401-3405.